<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">51453</article-id><article-id pub-id-type="doi">10.7554/eLife.51453</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Polyunsaturated fatty acid analogues differentially affect cardiac Na<sub>v</sub>, Ca<sub>v</sub>, and K<sub>v</sub> channels through unique mechanisms</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-155139"><name><surname>Bohannon</surname><given-names>Briana M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3720-1477</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172736"><name><surname>de la Cruz</surname><given-names>Alicia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-156855"><name><surname>Wu</surname><given-names>Xiaoan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172737"><name><surname>Jowais</surname><given-names>Jessica J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-156856"><name><surname>Perez</surname><given-names>Marta E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54058"><name><surname>Liin</surname><given-names>Sara I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8493-0114</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-116679"><name><surname>Larsson</surname><given-names>H Peter</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1688-2525</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Physiology and Biophysics</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Clinical and Experimental Medicine</institution>, <institution>Linköping University</institution>, <addr-line><named-content content-type="city">Linköping</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff3"><institution content-type="dept">Department of Physiology and Biophysics</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5759"><name><surname>Chanda</surname><given-names>Baron</given-names></name><role>Reviewing editor</role><aff><institution>University of Wisconsin-Madison</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>plarsson@med.miami.edu</email> (HL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>03</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e51453</elocation-id><history><date date-type="received"><day>29</day><month>08</month><year>2019</year></date><date date-type="accepted"><day>24</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Bohannon et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Bohannon et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-51453-v1.pdf"/><abstract><p>The cardiac ventricular action potential depends on several voltage-gated ion channels, including Na<sub>v</sub>, Ca<sub>v</sub>, and K<sub>v</sub> channels. Mutations in these channels can cause Long QT Syndrome (LQTS) which increases the risk for ventricular fibrillation and sudden cardiac death. Polyunsaturated fatty acids (PUFAs) have emerged as potential therapeutics for LQTS because they are modulators of voltage-gated ion channels. Here we demonstrate that PUFA analogues vary in their selectivity for human voltage-gated ion channels involved in the ventricular action potential. The effects of specific PUFA analogues range from selective for a specific ion channel to broadly modulating cardiac ion channels from all three families (Na<sub>v</sub>, Ca<sub>v</sub>, and K<sub>V</sub>). In addition, a PUFA analogue selective for the cardiac I<sub>Ks</sub> channel (Kv7.1/KCNE1) is effective in shortening the cardiac action potential in human-induced pluripotent stem cell-derived cardiomyocytes. Our data suggest that PUFA analogues could potentially be developed as therapeutics for LQTS and cardiac arrhythmia.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01-HL131461</award-id><principal-award-recipient><name><surname>Larsson</surname><given-names>H Peter</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Swedish Research Council</institution></institution-wrap></funding-source><award-id>2017-02040</award-id><principal-award-recipient><name><surname>Liin</surname><given-names>Sara I</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Sara I Liin, A patent application (62/032,739) has been submitted by the University of Miami with SIL and HPL as inventors. The authors declare no other competing interests.</p></fn><fn fn-type="conflict" id="conf3"><p>H Peter Larsson, A patent application (62/032,739) has been submitted by the University of Miami with SIL and HPL as inventors. The authors declare no other competing interests.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Source data used in this manuscript is openly available and is listed as a source data file for accessibility.</p></sec><supplementary-material><ext-link xlink:href="elife-51453-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>